According to the results of a new cohort study, female AF patients are more likely to have a stroke than their male counterparts.

Atrial fibrillation is one of the leading causes of strokes in the United States. It is for this reason that researchers sought to find out if gender played a role in determining which gender was most at risk of having a stroke. The other purpose of the study was to use that information to help determine the best course of action to take preventing strokes in AF patients, regardless of their gender.

During the study, researchers determined that women were at a slightly higher risk of stroke when it was learned that 3 percent of female AF patients suffered a stroke compared to the 1.6 percent of men that had a stroke. While many studies have already showed that women were more likely to have a stroke than men were, not much has been done to show why that is.

Some studies seemed to suggest that gender-specific stroke risks were caused by patients not receiving enough anticoagulant medication to help prevent the strokes. Warfarin has long been a favorite prescription for stroke prevention, while Multaq is another one. Multaq is an anticoagulant medication that is made by Sanofi-Aventis. The drug is rarely prescribed now due to its link to liver failure and a worsening of the heart condition. With such side effects as these occurring with current anticoagulant medications, research studies like this one can go a long way to helping scientists develop safer and more effective methods of treatment.

This new study was conducted by Avgil Tsadok and colleagues by studying administrative information in Quebec between 1998 and 2007. The data were composed of more than 80,000 AF patients.

If you or a loved one has suffered from liver failure or a worsening heart condition after being treated with Multaq, contact the attorneys at Greg Jones today for a free consultation. I am experienced at fighting Multaq lawsuits and may be able to help you recover money for your injuries.